Skip to content
WeighLab

eMed vs TeleCareSpot

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

eMed

Provider comparison

Shoppers who want brand-name Wegovy, pill or pen, with at-home lab testing and frequent check-ins, and who can budget for a membership on top of the drug.

Semaglutide / month
$149.99/moBrand Wegovy, starting price, plus the $149.99/mo membership
Tirzepatide / month
Not disclosed
Index 59/100 · Grade CChecked October 2026

TeleCareSpot

Provider comparison

Shoppers who want a monthly program with care-team support and are fine asking which states and doses it covers.

Semaglutide / month
$299/moCompounded; from price, monthly program
Tirzepatide / month
$399/moCompounded; from price, all dose levels included
Index 58/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

eMed has the higher Cost-Efficiency Index: 59/100 versus 58/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

eMed

TeleCareSpot

Semaglutide / month
eMed: $149.99/moBrand Wegovy, starting price, plus the $149.99/mo membership
TeleCareSpot: $299/moCompounded; from price, monthly program
Tirzepatide / month
eMed: Not disclosed
TeleCareSpot: $399/moCompounded; from price, all dose levels included
Semaglutide / year (modeled)
eMed: $3,600Includes $149.99/mo membership
TeleCareSpot: $3,588
Tirzepatide / year (modeled)
eMed: —
TeleCareSpot: $4,788
State availability
eMed: Coverage not published
TeleCareSpot: Coverage not published
Oral / sublingual option listed
eMed: Yes
TeleCareSpot: Yes
Brand-name access listed
eMed: Yes
TeleCareSpot: Not confirmed
Provider facts checked
eMed: October 2026
TeleCareSpot: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

eMed

Shoppers who want brand-name Wegovy, pill or pen, with at-home lab testing and frequent check-ins, and who can budget for a membership on top of the drug.

Reasons to consider it

  • Publishes its prices: a $49 screening, a $149.99 monthly membership, and Wegovy from $149.99 a month, charged only if you're approved
  • Prescribes FDA-approved Wegovy only, as the once-daily pill or the weekly pen
  • At-home blood test before you start, repeated at six and twelve months

What to weigh up

  • The membership is charged on top of the medication, so Wegovy's lowest price comes to about $300 a month
  • No compounded options and no tirzepatide or Zepbound
  • Its terms say the program is available only in certain states, without listing them

TeleCareSpot

Shoppers who want a monthly program with care-team support and are fine asking which states and doses it covers.

Reasons to consider it

  • Displays a LegitScript verification badge
  • The tirzepatide program says all prescribed dose levels are included in the monthly price
  • Cancel anytime by contacting support

What to weigh up

  • Prices are 'from' figures, and the semaglutide program doesn't say whether higher doses cost more
  • Doesn't list the states it serves
  • No medical director or compounding pharmacy is named

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

eMedTeleCareSpot
Normalized Cost/Month
eMed:
56/100
TeleCareSpot:
42/100
Price Transparency
eMed:
64/100
TeleCareSpot:
78/100
Nationwide Access
eMed:
24/100
TeleCareSpot:
24/100
Formulation Options
eMed:
77/100
TeleCareSpot:
77/100
Clinical Oversight
eMed:
88/100
TeleCareSpot:
83/100
Contract Flexibility
eMed:
55/100
TeleCareSpot:
61/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.